The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Neuroscience of Behavioral and Pharmacological Treatments for Addictions
Open accessAbstract
Summary Although substantial advances have been made in behavioral and pharmacological treatments for addictions, moving treatment development to the next stage may require novel ways of approaching addictions, particularly those derived from new findings regarding of the neurobiological underpinnings of addictions, while assimilating and incorporating relevant information from earlier approaches. In this review, we first briefly review theoretical and biological models of addiction and then describe existing behavioral and pharmacologic therapies for the addictions within this framework. We then propose new directions for treatment development and targets that are informed by recent evidence regarding the heterogeneity of addictions and the neurobiological contributions to these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785
The reward circuit: linking primate anatomy and human imaging
Haber, S. N., & Knutson, B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.129 · Cited by 3,718
Delay of gratification in children.
Mischel, W., Shoda, Y., & Rodriguez, M. L. (1989) · Science · doi:10.1126/science.2658056 · Cited by 3,397 · cited 2×
“This latter point seems particularly salient as individual differences in self-control during childhood predict important measures of functioning during adolescence and into adulthood (Lehrer, 2009; Mischel et al., 1989).”
Separate neural systems value immediate and delayed monetary rewards
McClure, S. M., Laibson, D. I., Loewenstein, G., & Cohen, J. D. (2004) · Science · doi:10.1126/science.1100907 · Cited by 3,089
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Research works printed but not linked: 180
- Achat-Mendes, 2010, Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: Studies with preferential antagonists in squirrel monkeys, J. Pharmacol. Exp. Ther., 334, 556, 10.1124/jpet.110.167619 · DOI
- Adewale, 2006, Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys, J. Pharmacol. Exp. Ther., 318, 922, 10.1124/jpet.106.105387 · DOI
- Alexander, 1990, Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions, Prog. Brain Res., 85, 119, 10.1016/S0079-6123(08)62678-3 · DOI · Paper page
- Andrews, 2010, Individuals family history positive for alcoholism show fMRI abnormalities in reward sensitivity that are related to impulsivity factors, Biol. Psychiatry
- Arias, 2008, Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers, Alcohol. Clin. Exp. Res., 32, 1159, 10.1111/j.1530-0277.2008.00735.x · DOI
- Baker, 2003, N-acetyl cysteine-induced blockade of cocaine-induced reinstatement, Ann. N. Y. Acad. Sci., 1003, 349, 10.1196/annals.1300.023 · DOI
- Balleine, 2007, Current trends in decision making, Ann. N. Y. Acad. Sci., 1104, xi, 10.1196/annals.1390.2226 · DOI
- Baptista, 2004, Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: Comparison between cocaine and a potent conventional reinforcer, J. Neurosci., 24, 4723, 10.1523/JNEUROSCI.0176-04.2004 · DOI · Paper page
- Bates, 2006, Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change, Psychol. Addict. Behav., 20, 241, 10.1037/0893-164X.20.3.241 · DOI · Paper page
- Bechara, 2003, Risky business: Emotion, decision-making, and addiction, J. Gambl. Stud., 19, 23, 10.1023/A:1021223113233 · DOI · Paper page
- Belin, 2008, High impulsivity predicts the switch to compulsive cocaine-taking, Science, 320, 1352, 10.1126/science.1158136 · DOI · Paper page
- Bell, 2001, Neurocognitive enhancement therapy with work therapy: Effects on neuropsychological test performance, Arch. Gen. Psychiatry, 58, 763, 10.1001/archpsyc.58.8.763 · DOI · Paper page
- Beveridge, 2008, Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3257, 10.1098/rstb.2008.0102 · DOI
- Bickel, 2008, Temporal discounting as a measure of executive function: Insights from the competing neuro-behavioral decision system hypothesis of addiction, Adv. Health Econ. Health Serv. Res., 20, 289, 10.1016/S0731-2199(08)20012-9 · DOI
- Bisaga, 2010, A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period, Drug Alcohol Depend., 111, 97, 10.1016/j.drugalcdep.2010.04.006 · DOI
- Blanco, 2009, A pilot study of impulsivity and compulsivity in pathological gambling, Psychiatry Res., 167, 161, 10.1016/j.psychres.2008.04.023 · DOI
- Blum, 1996, Reward deficiency syndrome, Am. Sci., 84, 132
- Botvinick, 2001, Conflict monitoring and cognitive control, Psychol. Rev., 108, 624, 10.1037/0033-295X.108.3.624 · DOI · Paper page
- Brady, 2005, Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress, Am. J. Psychiatry, 162, 1483, 10.1176/appi.ajp.162.8.1483 · DOI · Paper page
- Brauer, 1997, High dose pimozide does not block amphetamine-induced euphoria in normal volunteers, Pharmacol. Biochem. Behav., 56, 265, 10.1016/S0091-3057(96)00240-7 · DOI · Paper page
- Brewer, 2008, Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients, Biol. Psychiatry, 64, 998, 10.1016/j.biopsych.2008.05.024 · DOI · Paper page
- Brewer, 2008, The treatment of pathologic gambling, Addict. Disorders Treatment, 7, 1, 10.1097/ADT.0b013e31803155c2 · DOI
- Brewer, 2008, The neurobiology and genetics of impulse control disorders: Relationships to drug addictions, Biochem. Pharmacol., 75, 63, 10.1016/j.bcp.2007.06.043 · DOI · Paper page
- Bymaster, 2002, Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder, Neuropsychopharmacology, 27, 699, 10.1016/S0893-133X(02)00346-9 · DOI · Paper page
- Cahill, 2010, Nicotine receptor partial agonists for smoking cessation, Cochrane Database Syst. Rev., 12, CD006103
- Carroll, 2004, Choosing a behavioral therapy platform for pharmacotherapy of substance users, Drug Alcohol Depend., 75, 123, 10.1016/j.drugalcdep.2004.02.007 · DOI
- Carroll, 2005, Behavioral therapies for drug abuse, Am. J. Psychiatry, 162, 1452, 10.1176/appi.ajp.162.8.1452 · DOI · Paper page
- Carroll, 1994, One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects, Arch. Gen. Psychiatry, 51, 989, 10.1001/archpsyc.1994.03950120061010 · DOI · Paper page
- Chamberlain, 2009, Atomoxetine modulates right inferior frontal activation during inhibitory control: A pharmacological functional magnetic resonance imaging study, Biol. Psychiatry, 65, 550, 10.1016/j.biopsych.2008.10.014 · DOI · Paper page
- Chambers, 2001, A neurobiological basis for substance abuse comorbidity in schizophrenia, Biol. Psychiatry, 50, 71, 10.1016/S0006-3223(01)01134-9 · DOI · Paper page
- Chambers, 2007, A scale-free systems theory of motivation and addiction, Neurosci. Biobehav. Rev., 31, 1017, 10.1016/j.neubiorev.2007.04.005 · DOI
- Chambers, 2003, Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability, Am. J. Psychiatry, 160, 1041, 10.1176/appi.ajp.160.6.1041 · DOI · Paper page
- Chen, 2010, Synaptic plasticity in the mesolimbic system: Therapeutic implications for substance abuse, Ann. N Y Acad. Sci., 1187, 129, 10.1111/j.1749-6632.2009.05154.x · DOI
- Cheon, 2008, The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia, Int. J. Neuropsychopharmacol., 11, 971, 10.1017/S1461145708008663 · DOI
- Childress, 1999, Limbic activation during cue-induced cocaine craving, Am. J. Psychiatry, 156, 11, 10.1176/ajp.156.1.11 · DOI · Paper page
- Costello, 2010, Effects of treatment for tobacco dependence on resting cerebral glucose metabolism, Neuropsychopharmacology, 35, 605, 10.1038/npp.2009.165 · DOI
- Culbertson, 2011, Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers, Arch. Gen. Psychiatry, 10.1001/archgenpsychiatry.2010.193 · DOI
- Cutler, 2005, Are alcoholism treatments effective? The Project MATCH data, BMC Public Health, 5, 75, 10.1186/1471-2458-5-75 · DOI
- Dalley, 2009, Dopamine receptors in the learning, memory and drug reward circuitry, Semin. Cell Dev. Biol., 20, 403, 10.1016/j.semcdb.2009.01.002 · DOI
- Dalley, 2011, Impulsivity, compulsivity, and top-down cognitive control, Neuron, 69, 680, 10.1016/j.neuron.2011.01.020 · DOI · Paper page
- Dalley, 2007, Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement, Science, 315, 1267, 10.1126/science.1137073 · DOI · Paper page
- deCharms, 2008, Applications of real-time fMRI, Nat. Rev. Neurosci., 9, 720, 10.1038/nrn2414 · DOI · Paper page
- DeRubeis, 1999, Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons, Am. J. Psychiatry, 156, 1007, 10.1176/ajp.156.7.1007 · DOI · Paper page
- Economidou, 2011, Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking, Biol. Psychiatry, 69, 266, 10.1016/j.biopsych.2010.09.040 · DOI
- Eisenberg, 2008, Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials, CMAJ, 179, 135, 10.1503/cmaj.070256 · DOI · Paper page
- Ersche, 2006, Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers, Psychopharmacology (Berl.), 188, 364, 10.1007/s00213-006-0515-z · DOI
- Ersche, 2007, The neuropsychology of amphetamine and opiate dependence: Implications for treatment, Neuropsychol. Rev., 17, 317, 10.1007/s11065-007-9033-y · DOI · Paper page
- Evans, 2007, A pilot double-blind treatment trial of memantine for alcohol dependence, Alcohol. Clin. Exp. Res., 31, 775, 10.1111/j.1530-0277.2007.00360.x · DOI
- Fong, 2008, A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers, Pharmacol. Biochem. Behav., 89, 298, 10.1016/j.pbb.2007.12.025 · DOI · Paper page
- Frascella, 2010, Shared brain vulnerabilities open the way for nonsubstance addictions: Carving addiction at a new joint?, Ann. N. Y. Acad. Sci., 1187, 294, 10.1111/j.1749-6632.2009.05420.x · DOI · Paper page
- Frewen, 2008, Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review, Clin. Psychol. Rev., 28, 228, 10.1016/j.cpr.2007.05.002 · DOI · Paper page
- George, 2010, Individual differences in prefrontal cortex function and the transition from drug use to drug dependence, Neurosci. Biobehav. Rev., 35, 232, 10.1016/j.neubiorev.2010.05.002 · DOI · Paper page
- George, 2002, A placebo controlled trial of bupropion for smoking cessation in schizophrenia, Biol. Psychiatry, 52, 53, 10.1016/S0006-3223(02)01339-2 · DOI · Paper page
- Ghahremani, 2011, Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals, Neuropsychopharmacology, 10.1038/npp.2010.233 · DOI
- Giacobini, 2004, Cholinesterase inhibitors: New roles and therapeutic alternatives, Pharmacol. Res., 50, 433, 10.1016/j.phrs.2003.11.017 · DOI · Paper page
- Glimcher, 2004, Neuroeconomics: The consilience of brain and decision, Science, 306, 447, 10.1126/science.1102566 · DOI · Paper page
- Goldapple, 2004, Modulation of cortical-limbic pathways in major depression: Treatment specific effects of cognitive behavioral therapy compared to paroxetine, Arch. Gen. Psychiatry, 61, 34, 10.1001/archpsyc.61.1.34 · DOI · Paper page
- Grant, 2008, Predicting response to opiate antagonists and placebo in the treatment of pathological gambling, Psychopharmacology (Berl.), 200, 521, 10.1007/s00213-008-1235-3 · DOI · Paper page
- Grant, 2009, Imaginal desensitisation plus motivational interviewing for pathological gambling: A randomised controlled trial, Br. J. Psychol., 195, 266, 10.1192/bjp.bp.108.062414 · DOI
- Grant, 2007, N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study, Biol. Psychiatry, 62, 652, 10.1016/j.biopsych.2006.11.021 · DOI · Paper page
- Grant, 2010, Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: A pilot study, Psychopharmacology (Berl.), 212, 603, 10.1007/s00213-010-1994-5 · DOI · Paper page
- Grant, 2010, Introduction to behavioral addictions, Am. J. Drug Alcohol Abuse, 36, 233, 10.3109/00952990.2010.491884 · DOI · Paper page
- Grohman, 2006, Improving treatment response of cognitively impaired veterans with neuropsychological rehabilitation, Brain Cogn., 60, 203
- Gual, 2001, Acamprosate during and after acute alcohol withdrawal: A double-blind placebo-controlled study in Spain, Alcohol Alcohol., 36, 413, 10.1093/alcalc/36.5.413 · DOI
- Hall, 2002, Psychological intervention and antidepressant treatment in smoking cessation, Arch. Gen. Psychiatry, 59, 930, 10.1001/archpsyc.59.10.930 · DOI · Paper page
- Haney, 2010, Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans, Biol. Psychiatry, 67, 59, 10.1016/j.biopsych.2009.08.031 · DOI
- Haney, 2001, Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans, Psychopharmacology (Berl.), 155, 330, 10.1007/s002130100725 · DOI · Paper page
- Harsan, 2008, Recovery from chronic demyelination by thyroid hormone therapy: Myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging, J. Neurosci., 28, 14189, 10.1523/JNEUROSCI.4453-08.2008 · DOI · Paper page
- Havassy, 2004, Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery, Am. J. Psychiatry, 161, 139, 10.1176/appi.ajp.161.1.139 · DOI
- Heidbreder, 2010, Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders, Ann. N. Y. Acad. Sci., 1187, 4, 10.1111/j.1749-6632.2009.05149.x · DOI · Paper page
- Herin, 2010, Agonist-like pharmacotherapy for stimulant dependence: Preclinical, human laboratory, and clinical studies, Ann. N. Y. Acad. Sci., 1187, 76, 10.1111/j.1749-6632.2009.05145.x · DOI
- Higgins, 1991, A behavioral approach to achieving initial cocaine abstinence, Am. J. Psychiatry, 148, 1218, 10.1176/ajp.148.9.1218 · DOI · Paper page
- Highfield, 2001, Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats, Neuropsychopharmacology, 25, 320, 10.1016/S0893-133X(01)00227-5 · DOI · Paper page
- Hogarty, 2004, Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior, Arch. Gen. Psychiatry, 61, 866, 10.1001/archpsyc.61.9.866 · DOI · Paper page
- Holden, 2001, ‘Behavioral’ addictions: Do they exist?, Science, 294, 980, 10.1126/science.294.5544.980 · DOI · Paper page
- Holden, 2010, Psychiatry. Behavioral addictions debut in proposed DSM-V, Science, 327, 935, 10.1126/science.327.5968.935 · DOI · Paper page
- Horder, 2010, Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers, Int. J. Neuropsychopharmacol., 13, 1103, 10.1017/S1461145710000453 · DOI
- Hu, 2010, Serotonin 1B receptor imaging in alcohol dependence, Biol. Psychiatry, 67, 800, 10.1016/j.biopsych.2009.12.028 · DOI
- Irvin, 1999, Efficacy of relapse prevention: A meta-analytic review, J. Consult. Clin. Psychol., 67, 563, 10.1037/0022-006X.67.4.563 · DOI · Paper page
- Janes, 2010, Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence, Biol. Psychiatry, 67, 722, 10.1016/j.biopsych.2009.12.034 · DOI · Paper page
- Jentsch, 2009, Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats, Psychopharmacology (Berl.), 202, 497, 10.1007/s00213-008-1181-0 · DOI
- Johansson, 2006, Efficacy of maintenance treatment with naltrexone for opioid dependence: A meta-analytical review, Addiction, 101, 491, 10.1111/j.1360-0443.2006.01369.x · DOI · Paper page
- Johnson, 2008, Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 209, 10.1016/j.pnpbp.2007.07.030 · DOI
- Johnson, 2010, Delay discounting in current and former marijuana-dependent individuals, Exp. Clin. Psychopharmacol., 18, 99, 10.1037/a0018333 · DOI · Paper page
- Kable, 2007, The neural correlates of subjective value during intertemporal choice, Nat. Neurosci., 10, 1625, 10.1038/nn2007 · DOI · Paper page
- Kampman, 2006, A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms, Drug Alcohol Depend., 85, 129, 10.1016/j.drugalcdep.2006.04.002 · DOI
- Kenny, 2011, Reward mechanisms in obesity: New insights and future directions, Neuron, 69, 664, 10.1016/j.neuron.2011.02.016 · DOI · Paper page
- Kim, 2006, A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder, Proc. Natl. Acad. Sci. USA, 103, 19164, 10.1073/pnas.0510836103 · DOI
- Knackstedt, 2009, The role of cystine-glutamate exchange in nicotine dependence in rats and humans, Biol. Psychiatry, 65, 841, 10.1016/j.biopsych.2008.10.040 · DOI · Paper page
- Knutson, 2008, Anticipatory affect: Neural correlates and consequences for choice, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3771, 10.1098/rstb.2008.0155 · DOI · Paper page
- Kober, 2010, Prefrontal-striatal pathway underlies cognitive regulation of craving, Proc. Natl. Acad. Sci. USA, 107, 14811, 10.1073/pnas.1007779107 · DOI · Paper page
- Koob, 2010, Neurocircuitry of addiction, Neuropsychopharmacology, 35, 217, 10.1038/npp.2009.110 · DOI · Paper page
- Koob, 2010, Neurobiological mechanisms of addiction: Focus on corticotropin-releasing factor, Curr. Opin. Investig. Drugs, 11, 63
- Kosten, 2003, Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients, Drug Alcohol Depend., 70, 315, 10.1016/S0376-8716(03)00032-2 · DOI
- Kosten, 2006, Cue-induced brain activity changes and relapse in cocaine-dependent patients, Neuropsychopharmacology, 31, 644, 10.1038/sj.npp.1300851 · DOI · Paper page
- Krishnan-Sarin, 2007, Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers, Drug Alcohol Depend., 88, 79, 10.1016/j.drugalcdep.2006.09.006 · DOI · Paper page
- Krupitsky, 2007, Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients, Am. J. Psychiatry, 164, 519, 10.1176/ajp.2007.164.3.519 · DOI
- Lajtha, 2010, Heterogeneity of reward mechanisms, Neurochem. Res., 35, 851, 10.1007/s11064-009-0096-4 · DOI
- Lane, 2010, Diffusion tensor imaging and decision making in cocaine dependence, PLoS ONE, 5, e11591, 10.1371/journal.pone.0011591 · DOI
- Laucht, 2009, Impact of psychosocial adversity on alcohol intake in young adults: Moderation by the LL genotype of the serotonin transporter polymorphism, Biol. Psychiatry, 66, 102, 10.1016/j.biopsych.2009.02.010 · DOI
- Le Moal, 2009, Drug abuse: Vulnerability and transition to addiction, Pharmacopsychiatry, 42, S42, 10.1055/s-0029-1216355 · DOI
- LeSage, 2006, Current status of immunologic approaches to treating tobacco dependence: Vaccines and nicotine-specific antibodies, AAPS J., 8, E65, 10.1208/aapsj080108 · DOI
- Lewis, 2009, Learning sculpts the spontaneous activity of the resting human brain, Proc. Natl. Acad. Sci. USA, 106, 17558, 10.1073/pnas.0902455106 · DOI · Paper page
- Leyton, 2005, Cocaine craving, euphoria, and self-administration: A preliminary study of the effect of catecholamine precursor depletion, Behav. Neurosci., 119, 1619, 10.1037/0735-7044.119.6.1619 · DOI
- Li, 2006, Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence, Drug Alcohol Depend., 85, 205, 10.1016/j.drugalcdep.2006.04.008 · DOI · Paper page
- Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287 · DOI · Paper page
- Liechti, 2007, Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence, J. Neurosci., 27, 9077, 10.1523/JNEUROSCI.1766-07.2007 · DOI · Paper page
- Lim, 2002, Reduced frontal white matter integrity in cocaine dependence: A controlled diffusion tensor imaging study, Biol. Psychiatry, 51, 890, 10.1016/S0006-3223(01)01355-5 · DOI · Paper page
- Lim, 2008, Brain macrostructural and microstructural abnormalities in cocaine dependence, Drug Alcohol Depend., 92, 164, 10.1016/j.drugalcdep.2007.07.019 · DOI
- Longo, 2010, Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence, Addiction, 105, 146, 10.1111/j.1360-0443.2009.02717.x · DOI · Paper page
- Lussier, 2006, A meta-analysis of voucher-based reinforcement therapy for substance use disorders, Addiction, 101, 192, 10.1111/j.1360-0443.2006.01311.x · DOI · Paper page
- Maddux, 2000, Addiction or dependence?, Addiction, 95, 661, 10.1046/j.1360-0443.2000.9556611.x · DOI
- Mann, 2004, Pharmacotherapy of alcohol dependence: A review of the clinical data, CNS Drugs, 18, 485, 10.2165/00023210-200418080-00002 · DOI · Paper page
- Martell, 2005, Vaccine pharmacotherapy for the treatment of cocaine dependence, Biol. Psychiatry, 58, 158, 10.1016/j.biopsych.2005.04.032 · DOI · Paper page
- Martelle, 2007, J. Pharmacol. Exp. Ther., 321, 573, 10.1124/jpet.106.113571 · DOI
- Martínez-Raga, 2008, Modafinil: A useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies, Curr Drug Abuse Rev, 1, 213, 10.2174/1874473710801020213 · DOI
- Mason, 2010, The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence, Expert Opin. Drug Saf., 9, 177, 10.1517/14740330903512943 · DOI
- Mattick, 2004, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst. Rev., CD002207
- McLellan, 1993, The effects of psychosocial services in substance abuse treatment, JAMA, 269, 1953, 10.1001/jama.1993.03500150065028 · DOI · Paper page
- Meda, 2009, Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis, Behav. Pharmacol., 20, 390, 10.1097/FBP.0b013e32833113a3 · DOI · Paper page
- Moeller, 2001, Psychiatric aspects of impulsivity, Am. J. Psychiatry, 158, 1783, 10.1176/appi.ajp.158.11.1783 · DOI · Paper page
- Moeller, 2005, Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: Diffusion tensor imaging, Neuropsychopharmacology, 30, 610, 10.1038/sj.npp.1300617 · DOI · Paper page
- Moeller, 2007, Diffusion tensor imaging eigenvalues: Preliminary evidence for altered myelin in cocaine dependence, Psychiatry Res., 154, 253, 10.1016/j.pscychresns.2006.11.004 · DOI
- Nasrallah, 2009, Long-term risk preference and suboptimal decision making following adolescent alcohol use, Proc. Natl. Acad. Sci. USA, 106, 17600, 10.1073/pnas.0906629106 · DOI · Paper page
- Nunes, 2004, Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis, JAMA, 291, 1887, 10.1001/jama.291.15.1887 · DOI · Paper page
- O'Brien, 2006, What's in a word? Addiction versus dependence in DSM-V, Am. J. Psychiatry, 163, 764, 10.1176/ajp.2006.163.5.764 · DOI · Paper page
- Olive, 2010, Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction, Eur. J. Pharmacol., 639, 47, 10.1016/j.ejphar.2010.01.029 · DOI
- Orson, 2008, Substance abuse vaccines, Ann. N Y Acad. Sci., 1141, 257, 10.1196/annals.1441.027 · DOI · Paper page
- Partilla, 2006, Interaction of amphetamines and related compounds at the vesicular monoamine transporter, J. Pharmacol. Exp. Ther., 319, 237, 10.1124/jpet.106.103622 · DOI
- Peirce, 2006, Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study, Arch. Gen. Psychiatry, 63, 201, 10.1001/archpsyc.63.2.201 · DOI · Paper page
- Peterson, 2009, An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD, Am. J. Psychiatry, 166, 1286, 10.1176/appi.ajp.2009.08050724 · DOI · Paper page
- Petry, 2001, Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates, J. Abnorm. Psychol., 110, 482, 10.1037/0021-843X.110.3.482 · DOI · Paper page
- Poling, 2006, Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population, Arch. Gen. Psychiatry, 63, 219, 10.1001/archpsyc.63.2.219 · DOI · Paper page
- Potenza, 2010, Control yourself: Alcohol and impulsivity, Alcohol. Clin. Exp. Res., 34, 1303, 10.1111/j.1530-0277.2010.01214.x · DOI
- Potenza, 2006, Should addictive disorders include non-substance-related conditions?, Addiction, 101, 142, 10.1111/j.1360-0443.2006.01591.x · DOI · Paper page
- Potenza, 2007, Impulse control disorders and co-occurring disorders: Dual diagnosis considerations, J. Dual Diagn., 3, 47, 10.1300/J374v03n02_06 · DOI
- Potenza, 2008, Review. The neurobiology of pathological gambling and drug addiction: An overview and new findings, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 3181, 10.1098/rstb.2008.0100 · DOI · Paper page
- Potenza, 2009, Non-substance and substance addictions, Addiction, 104, 1016, 10.1111/j.1360-0443.2009.02619.x · DOI
- Potenza, 2007, Sex differences in the neural correlates of stress and craving in cocaine dependence, J. Womens Health (Larchmt), 16, 1108
- Potenza, 2005, Shared genetic contributions to pathological gambling and major depression in men, Arch. Gen. Psychiatry, 62, 1015, 10.1001/archpsyc.62.9.1015 · DOI · Paper page
- Ray, 2008, Effects of naltrexone during the descending limb of the blood alcohol curve, Am. J. Addict., 17, 257, 10.1080/10550490802138400 · DOI
- Reissner, 2010, Using glutamate homeostasis as a target for treating addictive disorders, Behav. Pharmacol., 21, 514, 10.1097/FBP.0b013e32833d41b2 · DOI · Paper page
- Renthal, 2008, Epigenetic mechanisms in drug addiction, Trends Mol. Med., 14, 341, 10.1016/j.molmed.2008.06.004 · DOI · Paper page
- Reynolds, 2006, Dimensions of impulsive behavior: Personality and behavioral measures, Personality and Individual Differences, 40, 305, 10.1016/j.paid.2005.03.024 · DOI · Paper page
- Robinson, 2001, Incentive-sensitization and addiction, Addiction, 96, 103, 10.1046/j.1360-0443.2001.9611038.x · DOI · Paper page
- Rutherford, 2010, Neurobiology of adolescent substance use disorders: Implications for prevention and treatment, Child Adolesc. Psychiatr. Clin. N. Am., 19, 479, 10.1016/j.chc.2010.03.003 · DOI
- Saxena, 2009, Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder, Mol. Psychiatry, 14, 197, 10.1038/sj.mp.4002134 · DOI · Paper page
- Schilström, 2007, Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors, Neuropsychopharmacology, 32, 43, 10.1038/sj.npp.1301087 · DOI
- Schlaug, 2009, Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy, Ann. N. Y. Acad. Sci., 1169, 385, 10.1111/j.1749-6632.2009.04587.x · DOI · Paper page
- Schmidt, 2010, Cocaine-induced neuroadaptations in glutamate transmission: Potential therapeutic targets for craving and addiction, Ann. N. Y. Acad. Sci., 1187, 35, 10.1111/j.1749-6632.2009.05144.x · DOI · Paper page
- Schultz, 2011, Potential effects of addictive drugs on neuronal reward, risk and decision mechanisms, Neuron, 69, 603, 10.1016/j.neuron.2011.02.014 · DOI · Paper page
- Seu, 2009, Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys, Psychopharmacology (Berl.), 202, 505, 10.1007/s00213-008-1250-4 · DOI
- Shearer, 2001, Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence, Addiction, 96, 1289, 10.1046/j.1360-0443.2001.96912898.x · DOI
- Shearer, 2003, Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence, Addiction, 98, 1137, 10.1046/j.1360-0443.2003.00447.x · DOI
- Sidhpura, 2010, Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence, Biol. Psychiatry, 67, 804, 10.1016/j.biopsych.2010.01.005 · DOI
- Sinha, 2008, Chronic stress, drug use, and vulnerability to addiction, Ann. N. Y. Acad. Sci., 1141, 105, 10.1196/annals.1441.030 · DOI · Paper page
- Sinha, 2009, Stress and addiction: A dynamic interplay of genes, environment, and drug intake, Biol. Psychiatry, 66, 100, 10.1016/j.biopsych.2009.05.003 · DOI
- Sinha, 2007, Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: Preliminary findings, Psychopharmacology (Berl.), 190, 569, 10.1007/s00213-006-0640-8 · DOI
- Sinha, 2005, Neural activity associated with stress-induced cocaine craving: A functional magnetic resonance imaging study, Psychopharmacology (Berl.), 183, 171, 10.1007/s00213-005-0147-8 · DOI · Paper page
- Sofuoglu, 2009, Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans, Psychopharmacology (Berl.), 207, 153, 10.1007/s00213-009-1643-z · DOI
- Somerville, 2010, A time of change: Behavioral and neural correlates of adolescent sensitivity to appetitive and aversive environmental cues, Brain Cogn., 72, 124, 10.1016/j.bandc.2009.07.003 · DOI · Paper page
- Srisurapanont, 2005, Naltrexone for the treatment of alcoholism: A meta-analysis of randomized controlled trials, Int. J. Neuropsychopharmacol., 8, 267, 10.1017/S1461145704004997 · DOI · Paper page
- Streeter, 2008, Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals, Neuropsychopharmacology, 33, 827, 10.1038/sj.npp.1301465 · DOI · Paper page
- Sulzer, 2011, How addictive drugs disrupt dopamine neurotransmission, Neuron, 69, 628, 10.1016/j.neuron.2011.02.010 · DOI · Paper page
- Tanabe, 2007, Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making, Hum. Brain Mapp., 28, 1276, 10.1002/hbm.20344 · DOI · Paper page
- Tolin, 2010, Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review, Clin. Psychol. Rev., 30, 710, 10.1016/j.cpr.2010.05.003 · DOI · Paper page
- Uhl, 2009, Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence, J. Neurogenet., 23, 272, 10.1080/01677060802572929 · DOI
- Uhl, 2004, The burden of complex genetics in brain disorders, Arch. Gen. Psychiatry, 61, 223, 10.1001/archpsyc.61.3.223 · DOI · Paper page
- Verdejo-García, 2008, Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies, Neurosci. Biobehav. Rev., 32, 777, 10.1016/j.neubiorev.2007.11.003 · DOI · Paper page
- Vocci, 2005, Medication development for addictive disorders: The state of the science, Am. J. Psychiatry, 162, 1432, 10.1176/appi.ajp.162.8.1432 · DOI · Paper page
- Volkow, 2004, Drug addiction: The neurobiology of behaviour gone awry, Nat. Rev. Neurosci., 5, 963, 10.1038/nrn1539 · DOI · Paper page
- Volkow, 2011, Addiction: Pulling at the neural threads of society, Neuron, 69, 599, 10.1016/j.neuron.2011.01.027 · DOI · Paper page
- Volkow, 2009, Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications, JAMA, 301, 1148, 10.1001/jama.2009.351 · DOI · Paper page
- Wang, 2009, Imaging of brain dopamine pathways: Implications for understanding obesity, J. Addict. Med., 3, 8, 10.1097/ADM.0b013e31819a86f7 · DOI · Paper page
- Weintraub, 2010, Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients, Arch. Neurol., 67, 589, 10.1001/archneurol.2010.65 · DOI · Paper page
- Wexler, 2001, Functional magnetic resonance imaging of cocaine craving, Am. J. Psychiatry, 158, 86, 10.1176/appi.ajp.158.1.86 · DOI · Paper page
- Wexler, 2011, Computerized cognitive remediation treatment for substance abuse disorders, Biol. Psychiatry, 69, 197, 10.1016/j.biopsych.2010.11.016 · DOI
- Wrase, 2007, Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics, Neuroimage, 35, 787, 10.1016/j.neuroimage.2006.11.043 · DOI · Paper page
- Xu, 2010, White matter integrity is associated with treatment outcome measures in cocaine dependence, Neuropsychopharmacology, 35, 1541, 10.1038/npp.2010.25 · DOI
- Zack, 2007, A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers, Neuropsychopharmacology, 32, 1678, 10.1038/sj.npp.1301295 · DOI · Paper page
Cited by
Allostasis: A model of predictive regulation
Sterling, P. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.06.004 · Cited by 1,073
Food cue reactivity and craving predict eating and weight gain: A meta-analytic review
Boswell, R. G., & Kober, H. (2016) · Obesity Reviews · doi:10.1111/obr.12354 · Cited by 703
Dong, G., & Potenza, M. N. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.005 · Cited by 559
Self-citationLeeman, R. F., & Potenza, M. N. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2550-7 · Cited by 448
Self-citationThe insula: a critical neural substrate for craving and drug seeking under conflict and risk
Naqvi, N. H., Gaznick, N., Tranel, D., & Bechara, A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12415 · Cited by 336
Metadata
- Authors
- Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 69
- Issue
- 4
- Pages
- 695-712
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2019758887
- Cited by
- 214
- References
- 68
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 897 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroscience of Behavioral and Pharmacological Treatments for Addictions. https://app.cochat.ai/papers/10.1016/j.neuron.2011.02.009
- The paper
- Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J. (2011). Neuroscience of Behavioral and Pharmacological Treatments for Addictions. Neuron. https://doi.org/10.1016/j.neuron.2011.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.